RESEARCH-USE BIOSIMILAR ANTIBODY
Gimsilumab
Monoclonal antibody · IgG1
Gimsilumab (MORAb-022) is a human anti-GM-CSF monoclonal antibody. Gimsilumab has the potential for the research of COVID-19 and rheumatoid arthritis (RA).
TARGETCSF2
YMonoclonal antibody
CATALOGSC-BS-505
CATALOG NUMBERSC-BS-505
MOLECULAR WEIGHTApprox. 145.765 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Gimsilumab (MORAb-022) is a human anti-GM-CSF monoclonal antibody. Gimsilumab has the potential for the research of COVID-19 and rheumatoid arthritis (RA).
Gimsilumab is a recombinant research-use antibody directed against CSF2.